The Oncology Institute Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, The Oncology Institute stock has a consensus rating of "Strong Buy" and an average price target of $8.20. The average 1-year stock price forecast is 40.17% higher than the current stock price, while the lowest is $7.00 (+19.66%) and the highest is $10 (+70.94%).

Price Target: $8.20 (+40.17%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$8.20	$8.00	$10
Change	+19.66%	+40.17%	+36.75%	+70.94%

Analyst Ratings

The average analyst rating for The Oncology Institute stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	3	3	3	3	3	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Larsen BTIG	BTIG	Buy Maintains $8 → $9	Buy	Maintains	$8 → $9	+53.85%	Jul 9, 2026
Matthew Shea Needham	Needham	Buy Reiterates $7	Buy	Reiterates	$7	+19.66%	Jul 7, 2026
Ben Haynor Lake Street	Lake Street	Buy Initiates $10	Buy	Initiates	$10	+70.94%	Jul 6, 2026
Robert LeBoyer Noble Financial	Noble Financial	Buy Reiterates $8	Buy	Reiterates	$8	+36.75%	May 8, 2026
Unknown Analyst B. Riley Securities No rating	B. Riley Securities	Buy Reiterates $6 → $8	Buy	Reiterates	$6 → $8	+36.75%	Mar 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

655.54M

from 502.73M

30.40%

from 502.73M

Revenue Next Year

825.48M

from 655.54M

25.92%

from 655.54M

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	203.00M	252.48M	324.24M	393.41M	502.73M	655.54M
Revenue Growth	8.26%	24.37%	28.42%	21.33%	27.79%	30.40%
Gross Profit	40.85M	52.09M	59.57M	54.00M	76.44M	106.63M
Gross Margin	20.12%	20.63%	18.37%	13.73%	15.20%	16.27%
Operating Income	-45.38M	-72.01M	-60.15M	-60.12M	-36.08M	-13.00M
Net Income	-10.93M	152.00K	-83.07M	-64.66M	-60.61M	-15.77M
Free Cash Flow	-13.34M	-40.79M	-16.33M	-7.42M	-11.00M	974.00K
No. Analysts	-	-	-	-	-	5

Revenue Forecast

Revenue	2026	2027	2028
High	675.9M
Avg	655.5M
Low	640.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	34.4%
Avg	30.4%
Low	27.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-